Skip to main content
. Author manuscript; available in PMC: 2013 Aug 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):489–494. doi: 10.1097/QAI.0b013e318256b310

Table 1.

Characteristics of men and non-pregnant and pregnant women at time of HAART initiation.

Demographics Male (n=3,176) Female, non-pregnant (n = 5,410) Female, pregnant (n = 587)
Follow-up time months 16 (7, 36) 19 (9, 37) 22 (8, 48)
Age years 36 (32, 40) 34 (29, 38) 30 (26, 33)
Employed 1642 (51.7) 2194 (40.6) 218 (37.1)
History of smoking 593 (18.7) 264 (4.9) 26 (4.4)

Clinical

HAART regimen
    d4t-3TC-EFV 2761 (86.9) 4580 (84.7) 38 (6.5)
    d4t-3TC-NVP 177 (5.6) 473 (8.7) 58 (9.9)
    d4t-3TC-LPVr 48 (1.5) 80 (1.5) 479 (81.6)
Weight kg 59 (53, 66) 57 (49, 65) 68 (60, 77)
Body mass index kg/m2 20.1 (18.3, 22.3) 22.2 (19.4, 25.5) 26.5 (23.3, 29.7)
Body mass index category
    < 18.5 818 (27.1) 927 (17.9) 9 (1.6)
    18.5-24.9 1901 (63.0) 2813 (54.3) 198 (35.9)
    25.0-29.9 252 (8.4) 961 (18.6) 221 (40.1)
    ≥ 30 46 (1.5) 478 (9.2) 123 (22.3)
WHO stage III or IV 1521 (47.9) 2355 (43.5) 105 (17.9)
Current tuberculosis 701 (22.1) 957 (17.7) 22 (3.8)

Laboratory

Hemoglobin, low 1581 (51.1) 2884 (54.8) 131 (31.0)
CD4 count cells/mm3 74 (22, 149) 92 (35, 162) 156 (103, 200)
CD4 count category
    ≤ 50 1245 (40.5) 1727 (32.9) 48 (8.8)
    51-100 593 (19.3) 1062 (20.2) 85 (15.6)
    101-200 937 (30.5) 1843 (35.1) 280 (51.3)
    201-350 261 (8.5) 508 (9.7) 124 (22.7)
    > 350 40 (1.3) 115 (2.2) 9 (1.7)
CD4 % 6.3 (2.8, 10.5) 7.2 (3.7, 11.5) 11.6 (7.8, 15.5)
Viral loadlog10 copies/ml 4.3 (3.6, 4.6) 4.2 (3.5, 4.6) 3.8 (1.7, 4.1)
Viral load category
    ≤ 400 163 (17.9) 289 (19.1) 31 (41.9)
    401-10,000 131 (14.4) 244 (16.1) 20 (27.0)
    > 10,000 615 (67.7) 979 (64.8) 23 (31.1)

Categorical variables expressed as number (% total); continuous variables as median (interquartile range).

After adjustment for altitude, lower limit of normal hemoglobin is 12.35 g/dl for men and 11.35 (10.35) g/dl for non-pregnant (pregnant) women.

Viral load was missing in 71% of men, 72% of non-pregnant women, and 88% of pregnant women.